Skip to main content

Table 4 Comparison of lipid data between patients with below- and abovemedian CETP levels

From: Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association

  Patients with CETP levels below the median (<2.6μg/mL; n = 21 ) Patients with CETP levels above the median ( 2.6 μg/mL; n = 23 ) p
Baseline CETP (p,g/mL) 2.12 ± 0.3 3.01 ± 0.44 <0.01
Post-treatment CETP (p,g/mL) 1.48 ± 0.36 2.44 ± 0.71 <0.01
Change in CETP (%) −28.9 ± 20.3 −19.2 ± 17.0 0.09
Baseline LDL-C (mg/dL) 143.5 ± 234.1 157.0 ± 34.9 0.14
Post-treatment LDL-C (mg/dL) 75.1 ± 15.2 103.6 ± 26.3 <0.01
Change in LDL-C (%) −46.4 ± 11.2 −33.1 ± 13.1 <0.01
Baseline sd LDL-C (mg/dL) 51.8 ± 16.3 51.7 ± 20.6 0.98
Post-treatment sd LDL-C (mg/dL) 23.9 ± 6.5 32.7 ± 12.1 <0.01
Change in LDL-C (%) −49.6 ± 13.7 −33.5 ± 19.2 <0.01